The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer

BACKGROUND: Oxaliplatin, irinotecan, 5-fluorouracil, and l-leucovorin (FOLFIRINOX) has become one of the first-line treatment options for advanced pancreatic cancer (PC). However, the relatively high rate of grade 3 or 4 adverse events associated with the standard dosage of FOLFIRINOX limits its wid...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Commun (Lond)
Egile Nagusiak: Wang, Zhi-Qiang, Zhang, Fei, Deng, Ting, Zhang, Le, Feng, Fen, Wang, Feng-Hua, Wang, Wei, Wang, De-Shen, Luo, Hui-Yan, Xu, Rui-Hua, Ba, Yi, Li, Yu-Hong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2019
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507030/
https://ncbi.nlm.nih.gov/pubmed/31068222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-019-0367-7
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak